Trial · NCT07895719
Exercise and Diet Supplements for Older Patients Undergoing TAVI: the IRON-TAVI Trial
NCT07895719, Not applicable, Recruiting, University Hospital of Ferrara
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Exercise and Diet Supplements for Older Patients Undergoing TAVI: the IRON-TAVI Trial. Trials, record NCT07895719. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895719
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Exercise and Diet Supplements for Older Patients Undergoing TAVI: the IRON-TAVI Trial
- NCT number
- NCT07895719
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 450 participants, estimated
- Lead sponsor
- University Hospital of Ferrara
- Conditions
- Aortic Stenosis Disease, Aortic Stenosis Symptomatic, Aortic Stenosis
- Interventions
- Personalized Multidomain Exercise Program, Oral Protein and Iron Nutritional Supplementation, Usual Care
- First posted
- 2026-10-26
- Last updated
- 2026-11-05
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to First All-Cause Death, Stroke, or Hospital Readmission for Cardiovascular Causes | From randomization through 12 months | Composite clinical outcome defined as the time from randomization to the first occurrence of all-cause death, stroke, or hospital readmission for cardiovascular causes. Clinical events will be independently adjudicated by a blinded Clinical Event Committee according to Valve Academic Research Consortium-3 definitions whenever applicable. |
| Secondary | All-cause death | From randomization through 12 months | Clinical outcome defined as the time from randomization to the first occurrence of all-cause death. |
| Secondary | Cardiovascular death | From randomization through 12 months | Clinical outcome defined as the time from randomization to the first occurrence of cardiovascular death. |
| Secondary | Stroke | From randomization through 12 months | Clinical outcome defined as the time from randomization to the first occurrence of stroke. |
| Secondary | Myocardial infarction | From randomization through 12 months | Clinical outcome defined as the time from randomization to the first occurrence of myocardial infarction. |
| Secondary | Hospital readmission for heart failure | From randomization through 12 months | Clinical outcome defined as the time from randomization to the first occurrence of hospital readmission for heart failure |
| Secondary | Hospital readmission for cardiovascular cause | From randomization through 12 months | Clinical outcome defined as the time from randomization to the first occurrence of hospital readmission for cardiovascular cause |
| Secondary | Hospital readmission for any cause | From randomization through 12 months | Clinical outcome defined as the time from randomization to the first occurrence of hospital readmission for any cause |
| Other | Primary safety endpoint | From randomization through 12 months | The primary safety endpoint is the cumulative occurrence of adverse events related to exercise training or dietary supplementation. These include, but are not limited to, angina resurgence, heart failure worsening, bleeding, falls or traumatism related to exercise training, and worsening renal function or other clinically relevant adverse effects related to dietary supplementation. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07895719
GET https://conductscience.org/api/trials/v1/NCT07895719/registered